Beam Therapeutics reported cash from operations of -$110.75M and free cash flow of -$111.96M for the quarter ended Sep 2026.This cash flow statement covers 31 quarters of results from Mar 2019 through Sep 2026, standardized by Business Quant from the company’s SEC filings.
Pull Beam Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
const res = await fetch("https://data.businessquant.com/statements?ticker=BEAM&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();